论文部分内容阅读
英国皇家诊所的医生认为:除非室上性起源已被确定,否则静脉应用异搏定(VeraPa-mil)对大多数室性心动过速患者不但无效,甚至非常有害,最好也不用于复杂性心动过速。分析32名患者的57次被误诊为室上性心动过速的室性心动过速发作对异搏定反应的研究中,发现静脉应用异搏定对45次发作(79％)无效,两名患者应用后心脏停搏,22例发作应用后有严重的血压降低,19名患者(59％)至少有一项严重的不良反应,6名患者有10次应
Doctors at the Royal Clinic believe that unless the supraventricular origin has been established, intravenous VeraPa-mil is not only ineffective in most ventricular tachycardia patients, it is even very detrimental and is best not used for complexity Tachycardia. In a study of 57 patients with ventricular tachycardia diagnosed in 57 patients misdiagnosed as supraventricular tachycardia in 32 patients, intravenous verapamil was found to be ineffective in 45 episodes (79%), two Severe blood pressure reduction after application of 22 patients after cardiac arrest, 19 patients (59%) had at least one serious adverse reaction, 6 patients had 10 times